154 related articles for article (PubMed ID: 37665493)
1. Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications.
Liu J; Wang H; Gu W; Zhao T; Fan W; Peng S
Int Ophthalmol; 2023 Dec; 43(12):4585-4593. PubMed ID: 37665493
[TBL] [Abstract][Full Text] [Related]
2. No side effects on rabbit retina or vitreous microenvironment by nd:YAG laser vitreolysis.
Lin T; Zhang M; Wu B; An Y; Pazo EE; Li R; Shen L
BMC Ophthalmol; 2024 Apr; 24(1):171. PubMed ID: 38627705
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
Luo J; An X; Kuang Y
J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
[TBL] [Abstract][Full Text] [Related]
4. Refractory open-angle glaucoma after neodymium-yttrium-aluminum-garnet laser lysis of vitreous floaters.
Cowan LA; Khine KT; Chopra V; Fazio DT; Francis BA
Am J Ophthalmol; 2015 Jan; 159(1):138-43. PubMed ID: 25308785
[TBL] [Abstract][Full Text] [Related]
5. LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.
Janeková A; Veith M; Fillová D; Janek M
Cesk Slov Oftalmol; 2022; 78(6):288-295. PubMed ID: 36543595
[TBL] [Abstract][Full Text] [Related]
6. Retinal Complications after Yttrium-Aluminum-Garnet Laser Vitreolysis for Vitreous Floaters.
Shields RA; Cheng OT; Ruby AJ; Williams GA; Wolfe JD
Ophthalmic Surg Lasers Imaging Retina; 2021 Nov; 52(11):610-613. PubMed ID: 34766848
[TBL] [Abstract][Full Text] [Related]
7. Cataracts induced by neodymium-yttrium-aluminium-garnet laser lysis of vitreous floaters.
Koo EH; Haddock LJ; Bhardwaj N; Fortun JA
Br J Ophthalmol; 2017 Jun; 101(6):709-711. PubMed ID: 27574177
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
Hangshuai Z; Yanhua J; Yao Z; Guangjin Z; Hongyan W; Fanlian C
Trials; 2024 Jan; 25(1):48. PubMed ID: 38218919
[TBL] [Abstract][Full Text] [Related]
9. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
Shah CP; Heier JS
JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
[TBL] [Abstract][Full Text] [Related]
10. Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.
Liu X; Wang Q; Zhao J
BMC Ophthalmol; 2020 Apr; 20(1):157. PubMed ID: 32306922
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
[TBL] [Abstract][Full Text] [Related]
12. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
Singh IP
Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
[TBL] [Abstract][Full Text] [Related]
14. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
Delaney YM; Oyinloye A; Benjamin L
Eye (Lond); 2002 Jan; 16(1):21-6. PubMed ID: 11913884
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: A randomized controlled trial.
Ludwig GD; Gemelli H; Nunes GM; Serracarbassa PD; Zanotele M
Eur J Ophthalmol; 2021 May; 31(3):909-914. PubMed ID: 33148023
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
[TBL] [Abstract][Full Text] [Related]
17. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
Su D; Shah CP; Hsu J
Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
[TBL] [Abstract][Full Text] [Related]
18. Effects of L-NAME and timolol on aqueous IL-1beta, IL-6, IL-8, TNF-alpha and NO levels after Nd:YAG laser iridotomy in rabbits.
Er H; Doganay S; Evereklioglu C; Cekmen M; Daglioglu MC; Isci N
Eur J Ophthalmol; 2002; 12(4):281-6. PubMed ID: 12219997
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of laser vitreolysis for vitreous floaters in posterior vitreous detachment.
Goh WN; Mustapha M; Zakaria SZS; Bastion MC
Indian J Ophthalmol; 2022 Aug; 70(8):3026-3032. PubMed ID: 35918966
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Follow-Up of Efficacy and Safety of YAG Vitreolysis for Symptomatic Weiss Ring Floaters.
Shah CP; Heier JS
Ophthalmic Surg Lasers Imaging Retina; 2020 Feb; 51(2):85-88. PubMed ID: 32084280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
